Highlights of Vitreoretina

Register      Login

VOLUME 8 , ISSUE 2 ( June, 2015 ) > List of Articles


Facoemulsificación en Ojos con Degeneración Macular Relacionada con la Edad

Andre Grixti, Evangelia Papavasileiou, Dominic Cortis, Balakrishna Vineeth Kumar, Som Prasad

Citation Information : Grixti A, Papavasileiou E, Cortis D, Kumar BV, Prasad S. Facoemulsificación en Ojos con Degeneración Macular Relacionada con la Edad. 2015; 8 (2):2-6.

DOI: 10.5005/hov-10102-08201

Published Online: 25-06-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


PDF Share
  1. C. J. Blair and J. Ferguson Jr., “Exacerbation of senile macular degeneration following cataract extraction,” American Journal of Ophthalmology, vol. 87, no. 1, pp. 77-83, 1979.
  2. A. Pollack, A. Marcovich, A. Bukelman, and M. Oliver, “Age-related macular degenera- tion after extracapsular cataract extraction with intraocular lens implantation,” Ophthal- mology, vol. 103, no. 10, pp. 1546-1554, 1996.
  3. I. Kaiserman, N. Kaiserman, A. Elhayany, and S. Vinker, “Cataract surgery is associa- ted with a higher rate of photodynamic therapy for age-related macular degeneration,” Ophthalmology, vol. 114, no. 2, pp. 278-282, 2007.
  4. R. Klein, B. E. K. Klein, T. Y. Wong, S. C. Tomany, and K. J. Cruickshanks, “The as- sociation of cataract and cataract surgery with the long-term incidence of age-related maculopathy: The Beaver Dam Eye Study,” Archives of Ophthalmology, vol. 120, no. 11, pp. 1551-1558, 2002.
  5. S. Cugati, P. Mitchell, E. Rochtchina, A. G. Tan, W. Smith, and J. J. Wang, “Cataract surgery and the 10- year incidence of age- related maculopathy: the Blue Mountain Eye Study,” Ophthalmology, vol. 113, no. 11, pp. 2020-2025, 2006.
  6. J. J. Wang, R. Klein, W. Smith, B. E. K. Klein, S. Tomany, and P. Mitchell, “Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains Eye Studies,” Ophthalmology, vol. 110, no. 10, pp. 1960-1967, 2003.
  7. E. E. Freeman, B. Munoz, S. K. West, J. M. Tielsch, and O. D. Schein, “Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies,” American Journal of Ophthalmology, vol. 135, no. 6, pp. 849-856, 2003.
  8. A. Bockelbrink, S. Roll, K. Ruether, A. Rasch, W. Greiner, and S. N. Willich, “Cataract surgery and the development or progression of age- related macular degeneration: a systematic review,” Survey of Ophthalmology, vol. 53, no. 4, pp. 359-367, 2008.
  9. G. N. Shuttleworth, E. A. Luhishi, and R. A. Harrad, “Do patients with age related macu- lopathy and cataract benefit from cataract surgery?” British Journal of Ophthalmology, vol. 82, no. 6, pp. 611-616, 1998. View at Google Scholar o View at Scopus
  10. A. M. Armbrecht, C. Findlay, P. A. Aspinall, A. R. Hill, and B. Dhillon, “Cataract surgery in patients with age-related macular degeneration: one-year outcomes,” Journal of Cata- ract and Refractive Surgery, vol. 29, no. 4, pp. 686-693, 2003.
  11. H. Baatz, R. Darawsha, H. Ackermann et al., “Phacoemulsification does not induce neo- vascular age-related macular degeneration,” Investigative Ophthalmology and Visual Science, vol. 49, no. 3, pp. 1079-1083, 2008.
  12. F. K. P. Sutter, M. Menghini, D. Barthelmes et al., “Is pseudophakia a risk factor for neo- vascular age-related macular degeneration?” Investigative Ophthalmology and Visual Science, vol. 48, no. 4, pp. 1472-1475, 2007.
  13. L. M. Dong, W. J. Stark, J. L. Jefferys et al., “Progression of age-related macular de- generation after cataract surgery,” Archives of Ophthalmology, vol. 127, no. 11, pp. 1412-1419, 2009.
  14. C. Y. Hooper, E. L. Lamoureux, L. Lim et al., “Cataract surgery in high-risk age-rela- ted macular degeneration: a randomized controlled trial,” Clinical and Experimental Ophthalmology, vol. 37, no. 6, pp. 570-576, 2009.
  15. M. Lundström, K. G. Brege, I. Florén, B. Lundh, U. Stenevi, and W. Thorburn, “Cataract surgery and quality of life in patients with age related macular degeneration,” British Journal of Ophthalmology, vol. 86, no. 12, pp. 1330-1335, 2002.
  16. E. Y. Chew, R. D. Sperduto, R. C. Milton et al., “Risk of advanced age- related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25,” Ophthalmology, vol. 116, no. 2, pp. 297-303, 2009.
  17. F. Forooghian, E. Agrón, T. E. Clemons, F. L. Ferris III, and E. Y. Chew, “Visual acui- ty outcomes after cataract surgery in patients with age-related macular degeneration: age- related eye disease study report no 27,” Ophthalmology, vol. 116, no. 11, pp. 2093-2100, 2009.
  18. H. Casparis, K. Lindsley, and N. B. Bressler, “Surgery for cataracts in people with age- related macular degeneration,” Cochrane Database of Systematic Reviews, no. 1, Arti- cle ID CD006757, 2009.
  19. H. Tabandeh, N. A. Chaudhry, D. S. Boyer, V. A. Kon-Jara, and H. W. Flynn Jr., “Outco- mes of cataract surgery in patients with neovascular age-related macular degeneration in the era of anti-vascular endothelial growth factor therapy,” Journal of Cataract and Refractive Surgery, vol. 38, no. 4, pp. 677-682, 2012.
  20. M. Muzyka-Wozniak, “Phacoemulsification in eyes with neovascular AMD treated with anti-VEGF injections,” European Journal of Ophthalmology, vol. 21, no. 6, pp. 766-770, 2011.
  21. P. J. Rosenfeld, H. Shapiro, J. S. Ehrlich, and P. Wong, “Cataract surgery in ranibi- zumab-treated patients with neovascular age-related macular degeneration from the phase 3 ANCHOR and MARINA trials,” American Journal of Ophthalmology, vol. 152, no. 5, pp. 793-798, 2011
  22. A. E. Fung, G. A. Lalwani, P. J. Rosenfeld et al., “An optical coherence tomography- guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration,” American Journal of Ophthalmology, vol. 143, no. 4, pp. 566.e2-583.e2, 2007
  23. R. F. Degenring, S. Vey, B. Kamppeter, W. M. Budde, J. B. Jonas, and G. Sauder, “Effect of uncomplicated phacoemulsification on the central retina in diabetic and non-diabetic subjects,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 1, pp. 18-23, 2007.
  24. M.-L. Bélair, S. J. Kim, J. E. Thorne et al., “Incidence of cystoid macular edema after ca- taract surgery in patients with and without uveitis using optical coherence tomography,” American Journal of Ophthalmology, vol. 148, no. 1, pp. 128.e2-135.e2, 2009.
  25. I. Perente, C. A. Utine, C. Ozturker et al., “Evaluation of macular changes after uncom- plicated phacoemulsification surgery by optical coherence tomography,” Current Eye Research, vol. 32, no. 3, pp. 241-247, 2007.
  26. H. N. Shelsta and L. M. Jampol, “PHarmacologic therapy of pseudophakic cystoid ma- cular edema: 2010 update,” Retina, vol. 31, no. 1, pp. 4-12, 2011.
  27. C. L. Lobo, P. M. Faria, M. A. Soares, R. C. Bernardes, and J. G. Cunha-Vaz, “Macular alterations after small-incision cataract surgery,” Journal of Cataract and Refractive Sur- gery, vol. 30, no. 4, pp. 752-760, 2004.
  28. J. B. Jonas, U. H. M. Spandau, F. Schlichtenbrede, T. Libondi, U. Vossmerbaeumer, and S. von Baltz, “Intravitreal bevacizumab combined with cataract surgery for treatment of exudative macular degeneration,” Journal of Ocular Pharmacology and Therapeutics, vol. 23, no. 6, pp. 599-600, 2007.
  29. Furino, A. Ferrara, N. Cardascia et al., “Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related generation,” Journal of Cataract and Refractive Surgery, vol. 35, no. 9, pp. 1518-1522, 2009.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.